Literature DB >> 23024235

The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer.

Tatsuo Maeyashiki1, Kenji Suzuki, Aritoshi Hattori, Takeshi Matsunaga, Kazuya Takamochi, Shiaki Oh.   

Abstract

OBJECTIVES: Ground-glass opacity (GGO) is a preoperative prognostic factor in resectable lung cancer. However, the impact of GGO on the T factor in the TNM staging system remains unclear and the maximum tumour dimension is also an uncertain measurement for assessing the prognosis of early lung cancer with a mixture of consolidation and GGO. Thus, we sought to determine which the better prognostic factor was, the size of the consolidation on computed tomography scan or the conventional maximum tumour dimension.
METHODS: Between January 2004 and January 2011, 398 consecutive clinical stage IA lung cancer patients underwent surgical resection at our hospital. Univariate and multivariate analyses were performed by the logistic regression procedure to determine the relationship between pathological lymph node metastasis-positive status and clinical or radiological findings such as the maximum dimensions of consolidation and the tumour, the presence of air bronchogram, pleural indentation and the preoperative serum carcinoembryonic antigen (CEA) level.
RESULTS: Of the 398 patients, 59 (14.8%) had pathological lymph node metastasis. Univariate analysis revealed four significant predictors of pathological nodal involvement: the presence of air bronchogram, the size of consolidation, the maximum tumour dimension and the preoperative CEA level (P < 0.01, respectively). In a multivariate analysis, the size of consolidation and the presence of air a bronchogram were significant predictors of nodal metastasis (P < 0.01, respectively).
CONCLUSIONS: The maximum dimension of the consolidation was an independent unfavourable prognostic factor, regardless of the maximum tumour dimension. This could lead to the more accurate prediction of pathological lymph node metastasis with both GGO and consolidation.

Entities:  

Mesh:

Year:  2012        PMID: 23024235     DOI: 10.1093/ejcts/ezs516

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  39 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

2.  The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation.

Authors:  Yiyang Wang; Rui Wang; Difan Zheng; Baohui Han; Jie Zhang; Heng Zhao; Jizhuang Luo; Jiajie Zheng; Tianxiang Chen; Qingyuan Huang; Yihua Sun; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-14       Impact factor: 4.553

3.  Predictors of pathological non-invasive lung cancer with pure-solid appearance on computed tomography to identify possible candidates for sublobar resection.

Authors:  Aritoshi Hattori; Tatsuo Maeyashiki; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-04-22       Impact factor: 2.549

4.  Effect of CT window settings on size measurements of the solid component in subsolid nodules: evaluation of prediction efficacy of the degree of pathological malignancy in lung adenocarcinoma.

Authors:  Qiong Li; Ya-Feng Gu; Li Fan; Qing-Chu Li; Yi Xiao; Shi-Yuan Liu
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

5.  Long-term outcomes of video-assisted thoracoscopic surgery lobectomy vs. thoracotomy lobectomy for stage IA non-small cell lung cancer.

Authors:  Risa Oda; Katsuhiro Okuda; Satoshi Osaga; Takuya Watanabe; Tadashi Sakane; Tsutomu Tatematsu; Keisuke Yokota; Hiroshi Haneda; Ryoichi Nakanishi
Journal:  Surg Today       Date:  2018-12-03       Impact factor: 2.549

6.  Limited resection versus lobectomy in early-stage non-small cell lung cancer.

Authors:  Paul A Toste; Jay M Lee
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

7.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

8.  A complicated clinical problem: surgical treatment decisions for patients with early-stage lung cancer.

Authors:  Jianfei Shen; Yang Liu; Chengyang Dai; Baofu Chen; Chang Chen; Gaetano Rocco; Alessandro Brunelli; Chia-Chuan Liu; Rene Horsleben Petersen; Jianxing He
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

9.  Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: a propensity-matched study.

Authors:  Tomohiro Murakawa; Junji Ichinose; Haruaki Hino; Kentaro Kitano; Chihiro Konoeda; Jun Nakajima
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

10.  The oncological outcomes of segmentectomy in clinical-T1b lung adenocarcinoma with a solid-dominant appearance on thin-section computed tomography.

Authors:  Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-10-15       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.